IRIS
PATTI, Giuseppe Rocco Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.579
EU - Europa 2.073
AS - Asia 1.424
SA - Sud America 18
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
Totale 8.108
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.577
IE - Irlanda 1.141
CN - Cina 845
UA - Ucraina 376
DE - Germania 358
TR - Turchia 318
SG - Singapore 204
IT - Italia 97
IN - India 54
FR - Francia 41
SE - Svezia 18
BR - Brasile 17
BE - Belgio 14
FI - Finlandia 9
EU - Europa 5
AU - Australia 4
GB - Regno Unito 4
NL - Olanda 4
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
ES - Italia 2
NZ - Nuova Zelanda 2
AT - Austria 1
BG - Bulgaria 1
CA - Canada 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
PY - Paraguay 1
TN - Tunisia 1
Totale 8.108
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.488
Dublin 1.139
Chandler 821
Santa Clara 383
Izmir 317
Nanjing 312
Boardman 193
Lawrence 189
Princeton 189
Singapore 130
Wilmington 130
Nanchang 104
L'aquila 85
Ashburn 84
New York 82
Pune 53
Shenyang 53
Hebei 42
Tianjin 40
Jiaxing 31
San Mateo 30
Kunming 29
Norwalk 29
Beijing 27
Changsha 27
Ann Arbor 20
Jinan 20
Shanghai 20
Los Angeles 19
Lanzhou 17
Mountain View 15
Brussels 14
Dallas 12
Zhengzhou 12
Changchun 10
Ningbo 10
Des Moines 7
Fremont 5
Hangzhou 5
Helsinki 5
Redwood City 5
Guangzhou 4
Lappeenranta 4
Munich 4
Phoenix 4
Chengdu 3
Dearborn 3
Fuzhou 3
Orange 3
Seattle 3
Tomsk 3
Bremen 2
Brno 2
Fairfield 2
Frankfurt am Main 2
Haikou 2
Jiaozuo 2
Menlo Park 2
Milan 2
Novara 2
Taiyuan 2
Taizhou 2
Wuhan 2
Amsterdam 1
Anyang 1
Aquila 1
Araripe 1
Asunción 1
Auckland 1
Avigliano 1
Baoding 1
Barcelona 1
Barreiras 1
Belo Horizonte 1
Berlin 1
Brasília 1
Budapest 1
Christchurch 1
Cruz Alta 1
Cuauhtémoc 1
Edinburgh 1
Ercolano 1
Fabbrico 1
Forest City 1
Foshan 1
Ganzhou 1
Hanover 1
Harbin 1
Hefei 1
Hengyang 1
Houston 1
Ilorin 1
Itapipoca 1
Itumbiara 1
Jacareí 1
Jinjiang 1
Joinville 1
Laurel 1
Limeira 1
Linfen 1
Totale 6.298
Salva come PNG Salva come JPEG
Nome #
Author`s Reply 75
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 69
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 68
Comparability of efficacy and safety results among phase III trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation 63
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 61
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery 61
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study 60
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 Studies. 60
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 59
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 59
Atorvastatin for reduction of myocardial damage during angioplasty trials 59
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 57
Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question! 57
Comparison among patients ≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents 57
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis 57
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 55
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial 55
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention 54
Early and long-term results of stenting of diffuse coronary artery disease 54
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry) 54
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 54
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 54
Myocardial infarction during pregnancy and postpartum: A review 54
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations 53
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly 53
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation 53
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 53
Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study 52
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 52
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 52
Are we ready for a gender-specific approach in interventional cardiology? 52
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 52
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 52
Comparison of the Feasibility and Effectiveness of Transradial Coronary Angiography Via Right Versus Left Radial Artery Approaches (from the PREVAIL Study) 51
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 51
Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome 51
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 51
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 51
Have statins beneficial anti-inflammatory as well as lipid-lowering effects 51
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 51
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: The prospective, multicentre observational PREvention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) 51
Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale 51
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study) 50
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 50
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 50
Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus 49
Atorvastatin pretreatment in early percutaneous coronary intervention 49
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study) 49
Prasugrel versus clopidogrel 49
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 49
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 49
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 49
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 49
Untitled 48
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 48
Apoptosis and post-infarction left ventricular remodeling 48
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 48
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 48
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis 48
Psychological stress as precipitating factor of the acute manifestations of ischemic cardiopathy 47
Association of virulent Helicobacter pylori strains with ischemic heart disease 47
Left atrial appendage closure using AMPLATZER™ devices: A large, multicenter, Italian Registry 47
Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study 47
Apoptosis in recent myocardial infarction 47
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 47
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 47
Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy 46
Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina 46
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension 46
Secondary cardiovascular prevention after acute coronary syndrome in clinical practice 46
Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis 46
Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy 46
Cardiogenic Shock Following Acute Myocardial Infarction: What's New? 46
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention 45
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 45
Prevention of myocardial damage during coronary intervention 45
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 45
Combining Antiplatelet and Anticoagulant Therapies 45
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: An unusual case of myocardial rupture 45
Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention 45
Clinical benefits of statin pretreatment in patients undergoing coronary revascularization 45
Giant left ventricular pseudoaneurysm complicating an acute myocardial infarction in patient with previous cardiac surgery: a case report 44
Dexamethasone-eluting stents and plasma concentrations of adhesion molecules in patients with unstable coronary syndromes: Results of the historically controlled SESAME study 44
The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences 44
Coronary stenting in patients with depressed left ventricular function: Acute and long-term results in a selected population 44
Key references: Basic fibrinolysis and thrombolysis selected references: 1987-1997 44
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 44
Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease 44
Percutaneous coronary interventions and statin therapy 44
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: A prospective single-center registry in high-risk patients 44
Inflammatory markers and coronary interventions: A potentially useful follow-up modality after stenting 44
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial) 44
Editorial: Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction 44
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis 44
Statin loading for acute coronary syndromes 44
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction 44
Improvement of myocardial ischemia by subclavian stent implantation in patients with internal mammary grafts: A case report and review of the literature 44
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis - A pilot study with ACTH-Depot plus tropisetron 43
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery - Results of the ARMYDA-3 (Atorvastatin for reduction of MYocardial dysrhythmia after cardiac surgery) study 43
Platelets GP-IIB-IIA receptor inhibitors in ischemic patients 43
Totale 5.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020854 0 0 0 0 0 191 263 3 207 2 0 188
2020/20211.176 8 193 3 189 190 1 198 1 176 1 216 0
2021/2022509 1 0 5 5 15 3 9 61 68 5 84 253
2022/20232.682 218 87 46 211 196 239 0 159 1.387 11 78 50
2023/2024483 98 25 31 22 39 192 2 39 0 24 2 9
2024/2025913 22 31 273 55 258 274 0 0 0 0 0 0
Totale 8.330